| Product NDC: | 0206-8852 |
| Proprietary Name: | Zosyn |
| Non Proprietary Name: | piperacillin sodium and tazobactam sodium |
| Active Ingredient(s): | 2; .25 g/10mL; g/10mL & nbsp; piperacillin sodium and tazobactam sodium |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0206-8852 |
| Labeler Name: | Pfizer Pharmaceuticals LLC, Pfizer Pharmaceutical LLC - Piperacillin |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA050684 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19931101 |
| Package NDC: | 0206-8852-16 |
| Package Description: | 10 VIAL, SINGLE-USE in 1 CARTON (0206-8852-16) > 10 mL in 1 VIAL, SINGLE-USE (0206-8852-08) |
| NDC Code | 0206-8852-16 |
| Proprietary Name | Zosyn |
| Package Description | 10 VIAL, SINGLE-USE in 1 CARTON (0206-8852-16) > 10 mL in 1 VIAL, SINGLE-USE (0206-8852-08) |
| Product NDC | 0206-8852 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | piperacillin sodium and tazobactam sodium |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19931101 |
| Marketing Category Name | NDA |
| Labeler Name | Pfizer Pharmaceuticals LLC, Pfizer Pharmaceutical LLC - Piperacillin |
| Substance Name | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM |
| Strength Number | 2; .25 |
| Strength Unit | g/10mL; g/10mL |
| Pharmaceutical Classes | beta Lactamase Inhibitor [EPC],beta Lactamase Inhibitors [MoA] |